Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 84066 refers to the laboratory test for measuring prostatic acid phosphatase (PAP) levels in the blood. Prostatic acid phosphatase is an enzyme that is primarily produced by the prostate gland and is found in high concentrations in seminal fluid. This enzyme plays a role in the fusion of endosomes, which is essential for creating an acidic environment necessary for various biological processes. Elevated levels of PAP can indicate several medical conditions, including benign prostatic hyperplasia (BPH), prostate cancer, infections, or infarction of the prostate. Additionally, conditions such as Paget's disease and Gaucher's disease may also lead to increased PAP levels. It is important to note that prostate manipulation procedures, such as biopsy or massage, can temporarily elevate PAP levels for a duration of 24 to 48 hours post-procedure. While the PAP test is not recommended for routine screening purposes, it can be valuable in predicting disease recurrence and monitoring the effectiveness of treatment in patients already diagnosed with prostate-related conditions. The test is performed by obtaining a blood sample through a venipuncture, and the serum is analyzed using a quantitative chemiluminescent immunoassay method, which provides precise measurements of PAP levels in the bloodstream.
© Copyright 2026 Coding Ahead. All rights reserved.
The prostatic acid phosphatase (PAP) test, represented by CPT® Code 84066, is indicated for the following conditions:
The procedure for obtaining the prostatic acid phosphatase (PAP) test involves several key steps:
After the PAP test is completed, the patient may be advised to resume normal activities. However, it is important to monitor for any potential side effects from the venipuncture, such as bruising or discomfort at the site of blood draw. The results of the PAP test will be interpreted by the healthcare provider, who will consider the levels in conjunction with the patient's clinical history and other diagnostic findings. Follow-up appointments may be necessary to discuss the results and any further actions required based on the findings.
| Short Descr | ASSAY PROSTATE PHOSPHATASE | Medium Descr | ASSAY OF PHOSPHATASE ACID PROSTATIC | Long Descr | Phosphatase, acid; prostatic | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | GA | Waiver of liability statement issued as required by payer policy, individual case | 77 | Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2013-01-01 | Changed | Medium Descriptor changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.